Land: Vereinigte Staaten
Sprache: Englisch
Quelle: NLM (National Library of Medicine)
ARTICAINE HYDROCHLORIDE (UNII: QS9014Q792) (ARTICAINE - UNII:D3SQ406G9X), EPINEPHRINE BITARTRATE (UNII: 30Q7KI53AK) (EPINEPHRINE - UNII:YKH834O4BH)
Pierrel S.p.A.
ARTICAINE HYDROCHLORIDE
ARTICAINE HYDROCHLORIDE 40 mg in 1 mL
SUBMUCOSAL
PRESCRIPTION DRUG
ORABLOC is indicated for local, infiltrative, or conductive anesthesia in both simple and complex dental procedures in adults and pediatric patients 4 years of age and older. ORABLOC is contraindicated in patients who are hypersensitive to products containing sulfites. Products containing sulfites may cause allergic-type reactions including anaphylactic symptoms and life-threatening or less severe asthmatic episodes in certain susceptible people. Sulfite sensitivity is seen more frequently in asthmatic than in non-asthmatic people [see Warnings and Precautions (5.5)] . Teratogenic Effects-Pregnancy Category C. There are no adequate and well-controlled studies in pregnant women with articaine with epinephrine. Articaine hydrochloride and epinephrine (1:100,000) has been shown to increase fetal deaths and skeletal variations in rabbits when given in doses approximately 4 times the maximum recommended human dose (MRHD). ORABLOC should be used during pregnancy only if the potential benefit justifies the potentia
ORABLOC® (articaine hydrochloride and epinephrine) injection is a clear, colorless solution available in 1.8 mL single-dose glass cartridges, packaged in boxes of 50 and 100 cartridges in the following two strengths (less than a full cartridge or more than one cartridge may be used for an individual patient): Both products are formulated with a 10% overage of epinephrine. Storage and Handling Store at 20° to 25°C (68° to 77°F); excursions permitted between 15° to 30°C (59° to 86°F) [See USP Controlled Room Temperature]. Protect from light. Do not freeze.
New Drug Application
ORABLOC- ARTICAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE INJECTION PIERREL S.P.A. ---------- HIGHLIGHTS OF PRESCRIBING INFORMATION THESE HIGHLIGHTS DO NOT INCLUDE ALL THE INFORMATION NEEDED TO USE ORABLOC® SAFELY AND EFFECTIVELY. SEE FULL PRESCRIBING INFORMATION FOR ORABLOC®. ORABLOC® (ARTICAINE HCL AND EPINEPHRINE) INJECTION, FOR INTRAORAL SUBMUCOSAL INFILTRATION USE INITIAL U.S. APPROVAL: 2000 RECENT MAJOR CHANGES Warnings and Precautions, Methemoglobinemia (5.4) 11/2018 INDICATIONS AND USAGE ORABLOC is a combination of articaine HCl, an amide local anesthetic, and epinephrine, a vasoconstrictor, indicated for local, infiltrative, or conductive anesthesia in both simple and complex dental procedures in adults and pediatric patients 4 years of age and older (1). DOSAGE AND ADMINISTRATION For dental procedures by intraoral submucosal infiltration or nerve block (2.1): For infiltration: 0.5 mL-2.5 mL (20 mg-100 mg articaine HCl) (2.1) For nerve block: 0.5 mL-3.4 mL (20 mg-136 mg articaine HCl) (2.1) For oral surgery: 1 ml-5.1 mL (40 mg-204 mg articaine HCl) (2.1) For most routine dental procedures, ORABLOC containing epinephrine 1:200,000 is preferred. However, when more pronounced homeostasis or improved visualization of the surgical field are required, ORABLOC containing epinephrine 1:100,000 may be used. (2.1) Maximum recommended dosages (2.2): Healthy adults: 7 mg/kg of articaine HCl and 0.0017mg/kg of epinephrine (equivalent to 0.175 mL/kg for either product presentation, articaine HCl and epinephrine 1:100,000 or 1:200,000) Pediatric patients 4-16 years: 7 mg/kg of articaine HCl and 0.0017mg/kg of epinephrine (equivalent to 0.175 mL/kg for either product presentation, articaine HCl and epinephrine 1:100,000 or 1:200,000) DOSAGE FORMS AND STRENGTHS Injection provided in glass cartridges (single-dose) containing: Articaine hydrochloride 4% (40 mg/mL) and epinephrine 1:200,000 (as epinephrine bitartrate 0.009 mg/mL) (3) Articaine hydrochloride 4% (40 mg/mL) and epinephrine 1:100,000 (as epinephrine bitart Lesen Sie das vollständige Dokument